Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...

The medicines may not only suppress appetite but also help curb alcoholism and other addictions. Read more at straitstimes.com.

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

Generics businesses achieve pretty defendable margins, yet their valuations are at material discounts to most of the Big ...

We recently published a list of 12 Stocks That Could Split in the Near Future. In this article, we are going to take a look ...

Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...

Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular ...

POLICE are appealing for the public’s help to find a missing 13-year-old girl last seen near Taunton. Lilly-May was last seen at around 1.15pm on Saturday, January 18 in Hatch Beauchamp. She is white, ...

This collaboration between Eli Lilly and a Top VC fund can redefine how Corporate VC (CVC) fuels innovation – not just in ...

Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis ...

Eli Lilly and Merck & Co. are partnering with Purdue University to launch the Young Institute Pharmaceutical Manufacturing ...